November 07, 2023 – Cancer Disparities
Mentors in the CURE program: Shrestha Ghosh, PhD, Peter van Galen, PhD, and Balaji Venkadakrishnan, PhD, share their experiences and answer questions.
News
-
-
October 31, 2023 – Cancer Disparities
The CURE Program endeavors to diversify the pipeline of cancer researchers, but could not do this work without the selfless donation of time by DF/HCC mentors, among whom are Shrestha Ghosh, PhD and Peter van Galen, PhD.
-
October 24, 2023 – Cancer Disparities
Dana-Farber/Harvard Cancer Center and Laurie H. Glimcher, MD Cancer Center Director Cordially invite you to the CURE Program Mentor Appreciation Reception.
-
October 19, 2023 – Cancer Disparities
The DF/HCC CURE and U54 Partnership Programs will have 11 summer trainees present their summer research projects at the Annual Biomedical Research Conference for Minoritized Students (ABRCMS) in Phoenix, AZ from November... -
October 11, 2023 – Announcements
Click here to listen to a radio interview featuring DF/HCC's Kimmie Ng, MD, MPH (DFCI) and Tim Rebbeck, PhD (HSPH).
-
October 10, 2023 – Announcements
The Commonwealth Fund Fellowship in Minority Health Policy at Harvard University (CFF) is pleased to announce the call for applications for the 2024-2025 year.
-
October 10, 2023 – Announcements
Postdoctoral applicants are encouraged to apply by November 1st with an anticipated start date of September 2024.
-
October 10, 2023 – Event Highlight
With the conviction that supporter and family involvement is crucial to student success, the CURE program holds a biannual family engagement night featuring an educational talk and updating attendees on the program’s...
-
October 05, 2023 – Announcements
Please Join us at the annual DF/HCC Lung Cancer Symposium on November 9th, 2023 as registration is now open; the theme this year is Small Cell Lung Cancer. We look forward to coming together and sharing knowledge to...
-
October 03, 2023 – Event Highlight
On behalf of the DF/HCC Neuro-Oncology Program leadership team, we are happy to announce a twice-yearly DF/HCC Joint Pediatric and Adult Neuro-Oncology Molecular Tumor Board. This promises to be a great first meeting to...